Financials MedBright AI Investments Inc.
Equities
MBAI
CA58406U1012
Financial & Commodity Market Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 CAD | 0.00% | -6.25% | -40.00% |
Valuation
Fiscal Period: February | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 19.11 | 19.11 | 0.5712 | 13.85 | 3.158 | 1.574 |
Enterprise Value (EV) 1 | 18.52 | 19.31 | 0.7242 | 14.2 | 2.097 | 1.791 |
P/E ratio | -70.4 x | -15.4 x | -0.2 x | -15.3 x | -2.53 x | -3.66 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | 9,967,673 x | 14,534,187 x |
EV / Revenue | - | - | - | - | 6,618,187 x | 16,539,303 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -33.6 x | 322 x | 0.8 x | -116 x | 13.5 x | -8.31 x |
FCF Yield | -2.98% | 0.31% | 124% | -0.87% | 7.41% | -12% |
Price to Book | 28.4 x | -71.7 x | -0.44 x | -10.5 x | 4.26 x | 5.06 x |
Nbr of stocks (in thousands) | 7,350 | 7,350 | 11,423 | 15,823 | 21,051 | 20,985 |
Reference price 2 | 2.600 | 2.600 | 0.0500 | 0.8750 | 0.1500 | 0.0750 |
Announcement Date | 6/28/18 | 6/28/19 | 8/13/20 | 7/30/21 | 6/30/22 | 6/29/23 |
Income Statement Evolution (Annual data)
Fiscal Period: February | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | 0.3168 | 0.1083 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | -0.1164 | -0.11 | -0.2304 | -0.4307 | -0.9392 | -0.26 |
Operating Margin | - | - | - | - | -296.48% | -240.13% |
Earnings before Tax (EBT) 1 | -0.2716 | -1.24 | -2.726 | -0.7188 | -1.205 | -0.4302 |
Net income 1 | -0.2716 | -1.24 | -2.726 | -0.7188 | -1.205 | -0.4302 |
Net margin | - | - | - | - | -380.45% | -397.3% |
EPS 2 | -0.0370 | -0.1687 | -0.2545 | -0.0574 | -0.0593 | -0.0205 |
Free Cash Flow 1 | -0.551 | 0.0599 | 0.9002 | -0.1229 | 0.1553 | -0.2154 |
FCF margin | - | - | - | - | 49.03% | -198.95% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 6/28/18 | 6/28/19 | 8/13/20 | 7/30/21 | 6/30/22 | 6/29/23 |
Balance Sheet Analysis
Fiscal Period: February | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 0.2 | 0.15 | 0.35 | - | 0.22 |
Net Cash position 1 | 0.59 | - | - | - | 1.06 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.55 | 0.06 | 0.9 | -0.12 | 0.16 | -0.22 |
ROE (net income / shareholders' equity) | -34.4% | -610% | 351% | 50% | 415% | -81.8% |
ROA (Net income/ Total Assets) | -3.96% | -5.23% | -29.6% | -135% | -49% | -8.63% |
Assets 1 | 6.867 | 23.71 | 9.206 | 0.5329 | 2.459 | 4.983 |
Book Value Per Share 2 | 0.0900 | -0.0400 | -0.1100 | -0.0800 | 0.0400 | 0.0100 |
Cash Flow per Share 2 | 0.1100 | 0 | 0.0100 | 0.0100 | 0.0600 | 0 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 6/28/18 | 6/28/19 | 8/13/20 | 7/30/21 | 6/30/22 | 6/29/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-40.00% | 12.04M | |
+4.64% | 76.71B | |
-2.44% | 60.51B | |
+6.12% | 45.84B | |
-3.35% | 36.54B | |
+3.90% | 34.95B | |
-21.17% | 11.91B | |
+7.18% | 9.68B | |
-30.20% | 7.8B | |
-6.00% | 7.35B |
- Stock Market
- Equities
- MBAI Stock
- Financials MedBright AI Investments Inc.